Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
Search by Keyword
Search by Category
Search by Format
Search by Type
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By
  • CE Credit available
    Contains 3 Component(s) Includes a Live In-Person Event on 04/04/2025 at 7:45 AM (PDT)

    April 4-6, 2025

    #ACMT2025 | Annual Scientific Meeting

    April 4-6, 2025
    Fairmont Hotel, Vancouver Canada

    The 2025 ACMT Annual Scientific Meeting (#ACMT2025) will take place from April 4-6 at the Fairmont Hotel in Vancouver, Canada. This event offers a unique opportunity for medical toxicology specialists to gather, learn, and network. Attendees will be exposed to cutting-edge research through a variety of educational sessions, with featured tracks covering Environmental & Public Health, Research, Addiction Toxicology, Professional Development, and New Insights! The meeting will also provide rich social and networking opportunities with receptions, business meetings, and awards ceremonies. Participants will leave equipped to enhance clinical decision-making, stay updated on emerging toxins and therapies, and foster multidisciplinary collaboration in managing complex toxicology cases. Continuing Education credits for Physicians, Pharmacists, and Nurses available.

    AACT Member Discount: AACT Members who are not already ACMT members, are eligible to receive a discounted registration rate. Just enter the following code at checkout to receive a $50 discount. Discount code: AACT2025


    Learner Objectives

    After attending the event, participants should be able to:

    • Enhance clinical decision-making in the field of Medical Toxicology.
    • Summarize knowledge of emerging toxins and novel therapies.
    • Organize multidisciplinary collaboration in the management of complex medical toxicology cases.

    Questions?

    Please write to ACMT at events@acmt.net

    Registration Rates

    Registration includes:

    • Access to the live in-person event on April 4-6, 2025
    • Access to the on-demand recording for 90 days after the event
    • Access to the speaker slides
    • Continuing Education credits are available for purchase for an additional fee. Click here for more info.


    ACMT Member RatesEarly-Bird

    Expires: Feb 21, 2025

    Regular Rate

    Begins: Feb 22, 2025


         Member Tier I: Full, Affiliate, International, Emeritus

    $650
    $750

         Member Tier II: Fellows

    $450
    $550

         Member Tier III: Residents, International - Developing Country


    $350

    $450

         Member IV: Medical Students


    $250

    $350

    Non-Member RatesEarly-Bird

    Expires: Feb 21, 2025

    Regular Rate

    Begins: Feb 22, 2025


         Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"


    $950

    $1050

         Non-member Tier II: Fellows, SPIs, Nurses, etc.


    $650

    $750

         Non-member Tier III: Educators & Emergency Responders


    $550

    $650

         Non-member IV: Residents & Students


    $450

    $550


    Early-Bird Rate

    Early-bird rates expire at midnight on FEBRUARY 21, 2025. Fees increase to the Regular Rate after this date, no exceptions.


    Membership Discounts

    ACMT Members: ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Team at membership@acmt.net. Learn more at: www.acmt.net/membership

    AACT Member Discount: AACT Members who are not already ACMT members, are eligible to receive a discounted registration rate. Just enter the following code at checkout to receive a $50 discount. Discount code: AACT2025


    Refunds and Cancellations

    Event registration cancellations received on or before February 17, 2025 (2/17/25) will receive a full refund less a 8% processing fee. Cancellations received between February 18, 2025 and March 18, 2025 (2/18/25-3/18/25) will receive a 50% refund. Cancellations made on or after March 19, 2025 (3/19/25) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.

    All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

    Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.


    Questions?

    For any questions, please email us at events@acmt.net.

    The ACMT Research Committee welcomes all types of original research of interest to medical toxicologists and their patients. Our goal is to enrich the attendee experience by offering presentations that share the latest science and clinical practices from the front lines of medical toxicology.

    There are four ways to present:

    • Platform presentations 
    • Lightning oral presentations
    • Moderated poster forums
    • Poster-only sessions

    ACMT will accept abstracts from September 1 – November 15, 2024. Abstracts will be peer-reviewed and acceptance will be based on content, available space, and overall program balance. All authors will be notified via email in mid-December. 

    Find Out More

    Agenda


    Click on the link below to access the most up-to-date agenda. All times listed in local, Pacific time.

    Maryann Amirshahi, PharmD, MD, MPH, PhD, FACMT

    Emergency Medicine Attending Physician, Professor Of Emergency Medicine, Co-Medical Director

    MedStar Washington Hospital Center, Georgetown University Hospital, National Capital Poison Center

    Dr. Maryann Amirshahi is a Professor of Emergency Medicine at Georgetown University School of Medicine and practices clinically at MedStar Washington Hospital Center, where she specializes in toxicology, addiction care, and emergency medicine. She holds a PharmD and medical degree, alongside an MPH focusing on environmental and occupational health, and a PhD in pharmacology and public health. Dr. Amirshahi is board-certified in emergency medicine, medical toxicology, addiction medicine, and clinical pharmacology, and is a registered pharmacist with over a decade of practice. Nationally recognized, she serves on the Board of Directors for the American College of Medical Toxicology and as co-medical director of the National Capital Poison Center. With nearly 200 peer-reviewed publications, her research spans medication safety, drug shortages, addiction treatment, and prescription drug misuse.

    Carl Baum, MD, MSc, FAAP, FACMT

    Professor of Pediatrics

    Yale School of Medicine

    Carl Baum, MD, FAAP, FACMT, is board-certified in Pediatric Emergency Medicine and in Medical Toxicology, and has over 25 years' experience in both subspecialties. He serves as attending physician in the Pediatric Emergency Department, and as Director of the state-funded Lead Poisoning and Regional Treatment Center. Nationally, Dr. Baum serves the following organizations: Executive Committee, Council on Children and Disasters, American Academy of Pediatrics, Medical Toxicology Subboard, American Board of Pediatrics/American Board of Emergency Medicine, National Biodefense Science Board, Administration for Strategic Preparedness & Response, US Department of Health and Human Services. In addition, he is a member of the International Society for Children's Health and the Environment.

    Caitlin Bonney, MD

    Assistant Professor of Emergency Medicine

    University of New Mexico

    Jeffrey Brent, MD, PhD, FACMT

    Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care) and Emergency Medicine

    University of Colorado School of Medicine and Public Health

    Jeffrey Brent, MD, PhD, is a Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care Medicine) and Emergency Medicine at the University of Colorado Schools of Medicine and Public Health. He did his fellowship in medical toxicology at the Rocky Mountain Poison and Drug Center, where he has been both medical director and fellowship director. He is a former President of the American Academy of Clinical Toxicology and a former Board member of the American College of Medical Toxicology. Dr. Brent is the senior editor of Critical Care Toxicology: the Diagnosis and Management of the Critically Poisoned Patient, currently in its second edition. Dr. Brent is Co-Principal Investigator of ACMT’s Toxicology Investigators Consortium.

    Nicholas Buckley, MD, FRACP

    Professor of Clinical Pharmacology

    Sydney Pharmacy School

    Nick Buckley is Professor of Clinical Pharmacology and a practicing clinical toxicologist consulting at RPA and through all the Poisons Centres in Australia. He is best known internationally for being a co-founder of the SACTRC collaboration, a centre of clinical toxicology research excellence in Sri Lanka with a focus on agrochemical poisoning and snakebite. http://www.sactrc.org/ Nick has been involved with contributing to the Australian Medicines Handbook since it was founded in 1998, and is now Chair of the Editorial Advisory Board. He was a founding Member of the Australian Advisory Committee on the Safety of Medicines (ACSOM). He is a past President of the Asia Pacific Association of Medical Toxicology. Nick is highly experienced in clinical epidemiology and research design. His research has attracted continuous project and program funding since 2002 and has resulted in an extensive publication record including 440+ peer reviewed journal articles and 22 book chapters. He has supervised or co-supervised over 20 higher degree students.

    Stephanie Carreiro, MD, PhD, FACMT

    Associate Professor, Director of the Tox(In)novation Lab

    University of Massachusetts Chan Medical School

    Dr. Stephanie Carreiro is an emergency medicine physician, medical toxicologist, and digital health researcher. She is a 2009 graduate of New York Medical College, and completed her emergency medicine residency in 2013 at Brown University.  She completed a medical toxicology fellowship in 2015, and recently received a PhD in Biomedical Sciences both at the University of Massachusetts. She is currently an Associate Professor, Director of the Tox(In)novation Lab, and Research Director in the Department of Emergency Medicine at University of Massachusetts Chan Medical School. Her current research program focuses on developing digital therapeutics for substance use disorder, understanding how patients use and engage with technology, and leveraging digital technology to promote health equity. She is the principal investigator multiple industry and federally funded research grants, including several awards from the National Institute on Drug Abuse and National Institute of Biomedical Imaging and Bioengineering. 

    Gerard Carroll, MD, FAAEM, FAEMS, FASAM, EMT-P

    EMS Fellowship Director

    Cooper Medical School of Rowan University

    Dr. Carroll is the Program Director for the EMS Fellowship at Cooper University Hospital. He is passionate about utilizing physician field response to translate the bedside, apprenticeship model of medical education into the field. His interests include addiction medicine and the role of urban EMS caring for underserved populations. He graduated from Brandeis University with a Bachelor of Arts with Honors in history. As an undergraduate, Dr. Carroll became passionate about emergency medical services, and following graduation became certified as a paramedic . He worked for nearly a decade in the New York City 911 system and was recognized for his service on the morning of the 9-11 attacks. He then earned his medical degree from Dartmouth Medical School where he was inducted into the Gold Humanism Honor Society. He completed emergency medicine residency at Temple University Hospital and completed a fellowship in emergency medical services at Cooper University Hospital. He is dual board certified in emergency medicine and emergency medical services.

    Dr. Carroll thrives on prehospital and disaster medicine and is passionate about resident, fellow, and especially about prehospital provider education. He was integral in the creation of our EMS fellowship and is excited to be the second program director. Dr. Carroll believes in the apprenticeship model of medical education and created Cooper’s prehospital physician response program to bring both physician-level care to patients and to move the bedside teaching model to the prehospital arena. Dr. Carroll loves the practice of academic emergency medicine and emergency medical services, and is not satisfied with the status quo. He believes strongly that EMS is a practice of medicine and as such needs to constantly be refocused on patient outcomes while optimizing its place in the health care system. He is a champion of nontraditional transport models, and helped spearhead the movement of addiction medicine into the field by educating paramedics about opioid use disorder and training them to rescue patients in withdrawal with medication-assisted therapy using buprenorphine. Dr. Carroll loves the varied practice environments of EM and EMS making academic, rural, prehospital, austere disaster deployment, and even cruise ship medicine a part of his regular medical practice.

    Alexis Cates, DO

    Attending Physician, Emergency Medicine and Medical Toxicology

    Ochsner Medical Center

    Alexis Cates, DO trained in Emergency Medicine and Medical Toxicology at Einstein Medical Center in Philadelphia, PA. She is currently located at Ochsner Medical Center in New Orleans, LA where she serves as the Emergency Medicine Residency Assistant Program Director and the Resident Medical Toxicology Rotation director. Professionally, she enjoys academics, perinatal toxicology, and health policy. She is the mother of two active boys, and she and her husband enjoy road trips and adventures with the kids.

    Peter Chai, MD, MMS

    Associate Professor

    Brigham and Women's Hospital

    Dr. Peter R Chai is an associate professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research primarily involves the development and implementation of technological solutions that detect and respond to changes in disease. These translational projects ranges from design of novel robotic and sensor systems in animal models to human clinical trials to test the implementation of injectable and ingestible sensor systems and overlying behavioral science architecture to respond to disease states.  Specifically, Dr. Chai is interested in applying ingestible electronic sensor systems to understand medication adherence in the context of substance use and HIV treatment/prevention. His work in developing ingestible sensors and their overlying behavioral interventions as closed loop systems to measure, reinforce and provide tools for PrEP and ART adherence has been funded by the National Institutes of Health and industry partners.

    Rachel Culbreth, PhD, MPH

    ToxIC Research Director

    American College of Medical Toxicology

    Dr. Culbreth joined the Toxicology Investigators Consortium/ACMT in May 2022. She received her PhD and MPH in epidemiology and biostatistics from Georgia State University. Her dissertation focused on the development of novel statistical methods to measure current and amount of substance use in a hybrid structural equation mixture model framework. She was an Assistant Professor in the College of Nursing and Health Professions at Georgia State University from 2019-2022, where she taught undergraduate and graduate-level research methods, healthcare leadership, and advanced statistical topics for pre-doctoral students. As ToxIC's Research Director, she leads new grant development and scientific dissemination through manuscripts and presentations, and enjoys working closely with clinical colleagues to advance medical toxicology research and practice.

    John Downs, MD, MPH

    Associate Professor and Director, Virginia Poison Center

    Virginia Commonwealth University Health System

    John W. Downs, MD MPH, is a graduate of the Virginia Military Institute and served two years as a US Army infantry officer, prior to attending medical school at the Uniformed Services University of the Health Sciences (USU). Dr. Downs completed residency training in internal medicine at Tripler Army Medical Center, Honolulu, Hawaii, and in occupational & environmental medicine at USU, where he also completed a Master of Public Health degree. Dr. Downs later completed a fellowship in medical toxicology at the Virginia Commonwealth University (VCU) Health System. Prior to his recent arrival as medical toxicology faculty at VCU in summer 2024, Dr. Downs was a US Army officer for more than 20 years. His final active-duty tour was at the Uniformed Services University where he was an Associate Professor and the Associate Program Director for the Occupational and Environmental Medicine residency, and an attending physician at Walter Reed National Military Medical Center. 

    His military medical experience includes multiple tours as senior medical officer to special operations and light infantry units to include deployments to operations in Iraq and Afghanistan. Dr. Downs’s public health experience includes service as Chief of the Department of Preventive Medicine at Fort Campbell, Kentucky, and Chief, Occupational & Environmental Medicine Service, Walter Reed National Military Medical Center during the COVID-19 pandemic. Dr. Downs is board certified as a physician in internal medicine, occupational & environmental medicine, and medical toxicology. Dr. Downs also holds allied health certifications as a certified public health professional (CPH), and Diplomate of the American Board of Toxicology (DABT). Dr. Downs is a recipient of the Army Surgeon General’s 9A Proficiency Designation in occupational and environmental medicine. He has authored more than 25 peer-reviewed publications. He is a Fellow of the American College of Physicians, and the American College of Occupational and Environmental Medicine.

    Leslie R. Dye, MD FACMT FASAM

    Medical Director, OneFifteen

    Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University

    Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

    William Eggleston, PharmD, DABAT, FAACT

    Clinical Assistant Director & Assistant Professor

    Upstate New York Poison Center & SUNY Upstate Medical University

    William Eggleston is originally from Binghamton, N.Y., and joins Binghamton University as a clinical assistant professor. He received his Doctor of Pharmacy degree from Wilkes University and completed a fellowship in clinical toxicology and emergency medicine at SUNY Upstate Medical University and with the Upstate New York Poison Center in Syracuse, N.Y. He comes to Binghamton from SUNY Upstate Medical University, where he served as an assistant professor in the Department of Emergency Medicine, and the Upstate New York Poison Center, where he worked as a clinical toxicologist.Eggleston is the director of the Opioid Research Center for Central New York (ORCC-NY), a multidisciplinary team of scientists, healthcare providers, and community partners working to develop innovative ideas and strategies for treating and preventing the harms of opioid use disorder. 

    Additionally, he is a member of the executive board of the New York State chapter of the American College of Clinical Pharmacy (ACCP).Eggleston is an active member of the American Academy of Clinical Toxicology where he serves as a member of the International Clinical Toxicology Recommendations Collaborative. His primary research interests are opioid use disorder treatment, opioid-related harm reduction strategies, and drug-induced cardiac toxicity. He is passionate about developing web-based content and tools within the Free Open Access Medication (FOAM) community that simplify drug-induced disease states in a manner that highlights interprofessional education and collaboration. His practice site is SUNY Upstate Medical University, where he works with an interprofessional inpatient toxicology consultation team and with the Upstate New York Poison Center, where he provides toxicology consultation, leads public health initiatives and performs public education.

    Timothy B. Erickson, MD, FACMT

    Emergency Medicine Physician, Division of Medical Toxicology

    Brigham and Women’s Hospital

    Dr. Timothy B. Erickson is an emergency medicine physician at the Brigham and Women’s Hospital in Boston, MA, USA where he serves as the Chief of Medical Toxicology in the Department of Emergency Medicine. He is also a teaching faculty member at Harvard Medical School. Dr. Erickson is also a core faculty member at the Harvard Humanitarian Initiative (HHI) in Cambridge, MA with expertise in environmental toxicology and crisis in climate change. He has active humanitarian health projects in Nepal and India as well as in conflict regions of Ukraine and Syria. 

    Dr. Erickson has been a member of multiple editorial boards and has a prolific academic history including publishing over 120 original journal articles and book chapters as well as editing 4 major textbooks. He has presented over 100 national and international invited lectures related to emergency medicine, toxicology, humanitarian global health, and wilderness/expedition medicine.

    Alyssa Falise, PhD, MSPH

    Research Associate, Toxicology Investigators Consortium

    American College of Medical Toxicology

    Alyssa joined the Toxicology Investigators Consortium/ACMT in November 2023. Alyssa earned her PhD in epidemiology from the University of Florida and her MSPH from the University of Miami. While at the University of Florida, Alyssa was trained in psychiatric epidemiology as a National Institute on Drug Abuse T32 Pre-Doctoral Fellow in the UF Substance Abuse Training Center in Public Health. In 2023, Alyssa was awarded the College on Problems of Drug Dependence’s Female Opioid-addiction Research and Clinical Experts (FORCE) Junior Investigator Award for her research addressing opioid use and non-medical use among middle and older adults.

    Ana Ferrer Dufol, MD

    Head of the Unit of Clinical Toxicology

    Clinic University Hospital

    Dr. Ana Ferrer Dufol holds a degree in Biochemistry and a Doctor of Medicine from the University of Zaragoza, where she was awarded the Extraordinary Prize for her doctorate. She is a specialist in Pathological and Forensic Anatomy and a graduate in Criminology and Clinical Toxicology from the Claude-Bernard University of Lyon (France). Since 1996, she has combined her role as a professor in the Area of Toxicology and Health Legislation at the University of Zaragoza with her position as Section Head of the Clinical Toxicology Unit at the University Clinical Hospital, a reference unit in Aragon.

    In addition, she is a member of the scientific committee of the Aragonese Food Safety Agency. Her professional expertise has enabled her to coordinate, for more than 11 years, a toxicovigilance program with the Ministry of Health to monitor cases of poisoning caused by chemical products in hospital emergency services. Her work has been published in international journals, particularly on toxic epidemics related to pesticide agents.

    Charlotte Goldfine

    Medical Toxicologist

    Brigham and Women's Hospital

    Charlotte Goldfine, MD is an emergency medicine physician and medical toxicologist at Brigham and Women’s Hospital (BWH). She is the course director for the Harvard-Affiliated Emergency Medicine Residency toxicology core rotation and the BWH site fellowship director for the Harvard Toxicology Fellowship. Her research is focused on medication safety, medical education, and advances in digital health technologies, novel therapeutics, and drug-delivery systems in the treatment of substance use disorders.

    Arielle Graham, MD

    Associate Psychiatrist & Instructor

    Brigham and Women’s Hospital & Harvard Medical School

    Dr. Graham is double board-certified (adult and child/adolescent) psychiatrist with expertise in young adult mental health, emergency mental health, consultation-liaison psychiatry, medical education/training, clinical informatics and medical writing/editing. She completed her psychiatry residency and child and adolescent psychiatry fellowship at UMass Chan Medical School, following which she worked as an attending psychiatrist at UMass Memorial Medical Center and an Assistant Professor of Psychiatry and Pediatrics at UMass Chan Medical School. She is currently an Associate Psychiatrist at Brigham and Women’s Hospital and a Clinical Instructor in Psychiatry at Harvard Medical School.

    Powell Graham, MD

    Assistant Professor of Emergency Medicine

    University of Massachusetts Chan Medical School

    Dr. Graham works as a board-certified medical toxicologist and an emergency medicine physician at UMass Chan Medical School in Worcester, MA. There, he is also the director of the outpatient toxicology clinic. He acts as an educator, clinician, and researcher in these capacities. He completed his toxicology fellowship in 2022 at UMass after completing his residency in emergency medicine also at UMass. His current academic and research interests include psychedelics, addiction medicine, cannabinoids, and harm reduction.

    Rachel Haroz, MD, FAACT

    Medical Director, Center for Healing

    Cooper University Health Care

    Dr. Haroz is Associate Professor in the Department of Emergency Medicine at Cooper Medical School of Rowan University, Division Head of Toxicology and Addiction Medicine, and Medical Director at the Center for Healing. She is board certified in emergency medicine, medical toxicology, and addiction medicine, obtaining her BA in biology from Brandeis University, her MD from Tufts University and completed a residency in emergency medicine and fellowship in medical toxicology. She has spent the last 17 years working in inner city emergency departments, mostly in the Camden area where opioid intoxication, abuse and dependency are rampant. She helped build and now staffs the Outreach Clinic at the Urban Health Institute at Cooper University Hospital in Camden, New Jersey, an addiction medicine specialty clinic dedicated to treating patients with substance use disorders and helped build an integrated clinic for patients with HIV and substance use disorders. In 2016 she helped create and implement an initiative to prescribe buprenorphine from the Emergency Department and bridge patients to treatment to various community partners. In 2019 she helped launch an innovative program aimed at initiating buprenorphine via paramedics in the field. She is also heavily involved in education of residents, medical students, and pharmacists and organizes education forums focused on topics related to opioid dependency and treatment.

    Andrew Herring, MD

    Systemwide Medical Director, Substance Use Disorder Treatment

    Alameda Health System

    Andrew is an Attending Emergency Physician and Associate Director of Research at Highland Hospital-Alameda Health System in Oakland, as well as Medical Director of the hospital’s substance use disorder treatment program and Attending Physician at its interdisciplinary pain medicine program. His current research focuses on emergency department treatment of opioid use disorders and pain management. Andrew is an assistant clinical professor at the University of California, San Francisco. He conducted health policy research as a Fulbright Scholar in Central America. He is board-certified in emergency medicine, addiction medicine, and pain medicine. Andrew graduated from Harvard Medical School and completed residency in emergency medicine at Highland Hospital.

    Daniel Hryhorczuk, MD, FACMT

    Professor Emeritus

    University of Illinois Chicago

    Daniel Hryhorczuk was born in Champaign, Illinois in the “heart of the heart of the country.” The son of Ukrainian immigrants, he grew up in Chicago’s Ukrainian Village neighborhood. He received his BA in English (creative writing) from Northwestern University where his short story “The Ice Cross” won first place in the Orgy of the Arts. He received his MD and MPH degrees from the University of Illinois and pursued a career in medicine, toxicology, and global health before returning to creative writing. His first novel, Caught in the Current, revisited the world of his youth -- ethnic America and offbeat Europe during the psychedelic sixties. 

    The Midwest Book Review described it as “one amazing read and decidedly establishes Daniel Hryhorczuk as a talented author of wit, imagination, and a fundamentally gifted storyteller.” His second novel, Myth and Madness, explores Ukraine’s “revolution of dignity” during the winter of 2013/14. He has received commendations from the City of Chicago, the White House, and the Ukrainian government for his work on social and health issues in Ukraine. His most recent novel, Amerikana, explores the country of his birth and what it truly means to be an American. He lives in the Chicago area with his wife Christine.

    Geoffrey Isbister, MD

    Professor, School of Medicine and Public Health

    University of Newcastle

    I am a Professor and NHMRC Senior Research Fellow at the University of Newcastle. I am a consultant clinical toxicologist and emergency physician, Director of the Department of Clinical Toxicology, Calvary Mater Hospital and consultant toxicologist to the NSW Poisons Information Centre. I was made a Member of the Order of Australia in 2019 for my contribution to toxicology. I am President Elect of the Asia Pacific Assocation of Medical Toxicologists. My major area of research is snake bite. I have published over 375 papers and received $20 million in research funds.

    Heath A. Jolliff, DO, FACMT, FACEP, FAAEM, ACC

    Certified Executive Physician Coach

    Physician Coaching Solutions, LLC & Mid-Ohio Toxicology Services, LLC

    Dr. Health Jolliff has more than 30 years of clinical practice and is dual board-certified in Emergency Medicine and Medical Toxicology. He is now certified as an executive coach, working with physicians in all stages of their careers. He works to help them find focus, direction and solutions to their current and future career challenges. He works as an an educator, a national speaker and has his own consulting business.

    William "Russ" Kerns, II, MD, FACMT, FACEP

    Emeritus Professor of Emergency Medicine

    Carolinas Medical Center

    Dr. Kerns trained in Emergency Medicine and Medical Toxicology and served as Professor in both disciplines at Carolinas Medical Center for 33 years. Faculty roles included leadership of the Medical Toxicology Fellowship and clinical division, consultation for the Carolinas Poison Center, and research. Research interests included antidotes, envenomation, and resuscitation of cardiotoxic drugs. He also served the ACMT focusing on advancing research and education.

    Joshua D. King, MD, FACMT

    Associate Professor, Medicine and Pharmacy; Medical Director, Maryland Poison Center

    University of Maryland School of Medicine

    Joshua D. King, MD, FACMT is an Associate Professor of Medicine and Pharmacy and the Medical Director of the Maryland Poison Center at the University of Maryland School of Medicine. He earned his medical degree from Penn State College of Medicine, followed by an Internal Medicine residency and chief residency at the University of Virginia. He then completed a Nephrology fellowship at Johns Hopkins Hospital and, after returning to the University of Virginia as a nephrologist, pursued further specialization through a Medical Toxicology fellowship. Dr. King is a dual-specialized clinician-educator in nephrology and medical toxicology, with clinical expertise in extracorporeal treatments for poisonings, therapeutic drug removal, ICU nephrology, and medical education. At the University of Maryland Medical Center, he provides care through both the nephrology and medical toxicology consultation services, focusing on hospitalized patients. In addition to his clinical work, Dr. King is deeply involved in graduate medical education, training residents and fellows, as well as teaching undergraduate medical students. As the Medical Director of the Maryland Poison Center, he oversees the clinical management of poisoning, envenomation, and overdose cases for both the public and healthcare providers. His role also includes educating medical and pharmacy students and supervising physicians who rotate through the center. Dr. King’s research interests lie at the intersection of nephrology and toxicology, particularly in the extracorporeal removal of toxins through modalities such as dialysis and apheresis.

    Michael J. Kosnett, MD, MPH, FACMT

    Associate Clinical Professor, Department of Medicine

    University of Colorado School of Medicine

    Michael J. Kosnett, MD, MPH, FACMT has 34 years of experience as a physician specializing in medical toxicology and occupational and environmental health. He is board certified in internal medicine, medical toxicology, and preventive medicine (occupational medicine). He has served in a leadership and advisory capacity to multiple national and international medical and public health organizations. This includes service as past president of the American College of Medical Toxicology and a member of the Committee on Toxicology of the National Academies of Sciences, Engineering, and Medicine and the Board of Scientific Counselors of the National Institute for Occupational Safety and Health. In addition, Dr. Kosnett has served as a consultant and temporary advisor to the World Health Organization; EPA Science Advisory Board expert panels; and advisory committees of the CDC National Center for Environmental Health and ATSDR. He has also served as a medical toxicology consultant to the US Army Public Health Command, the US Air Force Science Advisory Board, and the US Navy Naval Air Systems Command. In 2016, the American College of Medical Toxicology awarded Dr. Kosnett the Matthew J. Ellenhorn Award, a career achievement award that recognizes “extraordinary contributions to the field of medical toxicology.”

    Venkat Kotamraju, MD, MRCSEd, PGDip, FEBEM, FRCEM

    Clinical Toxicologist & Consultant in Emergency Medicine; Emergency Medicine Training Program Director

    Royal Derby Hospital & Health Education East Midlands

    Dr. Venkat Kotamraju is a Consultant in Emergency Medicine at Royal Derby Hospital, UK, with over 20 years of experience. He is the CESR Programme Director, Teaching Lead, and Training Program Director (TPD) for Exams at Health Education East Midlands, focusing on medical education and leadership.

    A Fellow of the Royal College of Emergency Medicine (UK) and the European Board of Emergency Medicine, Dr. Kotamraju is also a certified Medical Examiner and Medical Appraisal Lead. He has contributed extensively as an RCEM Examiner, CESR Portfolio Assessor, and Vice Chair of the International Federation of Emergency Medicine's Quality and Safety Group.

    An ATLS Course Director and global educator, he leads exam preparation courses in the UK, UAE, and India. His key interests include emergency toxicology, leadership, patient safety, and quality improvement, making him a recognized leader in Emergency Medicine and education.

    Alex Krotulski, PhD

    Associate Director of Toxicology & Chemistry

    The Center for Forensic Science Research and Education

    Dr. Alex Krotulski serves as an Associate Director at CFSRE working in the areas of forensic toxicology and forensic chemistry and is the Program Manager for NPS Discovery. Dr. Krotulski holds faculty appointment and serves as the Assistance Program Director for the Thomas Jefferson University Master of Science in Forensic Toxicology (MSFT) program and was recently appointed as an Associate Editor for the Journal of Analytical Toxicology. Dr. Krotulski received his Doctor of Philosophy degree in Analytical Chemistry from Temple University in 2019 following receipt of his Master of Science degree in Forensic Science from Arcadia University in 2015 and Bachelor of Science in Chemistry from Loyola University New Orleans in 2013.

    Jeffrey Lai, MD

    Assistant Professor and Director, Medical Toxicology Fellowship

    UMass Chan Medical School

    Jeffrey Lai, MD, is an emergency physician and medical toxicologist. He completed his undergraduate studies at the University of California, Berkeley; medical school at the University of Pittsburgh; and emergency medicine residency and medical toxicology fellowship at the University of Massachusetts. He is the program director of the medical toxicology fellowship at UMass Chan Medical School, and his academic interests include medical education, the application of novel technologies to the treatment of substance use disorders, and the surveillance of impairing substances in patients with severe traumatic injurie

    Bruce Lanphear, MD, MPH

    Professor of Health Sciences

    Simon Fraser University

    Dr. Bruce Lanphear, a Professor at Simon Fraser University, has conducted research on the sources of lead exposure and impacts of lead poisoning for over 25 years. He is currently principal investigator for a study examining fetal and early childhood exposures to prevalent environmental neurotoxins including lead, pesticides, mercury, alcohol, PCB's and environmental tobacco smoke. A component of the study is the investigation of the contribution of residential hazards and residential injuries to children's health. This project recently received funding to follow the original birth cohort, until the children are five years of age. This will allow follow-up for determining the efficacy of lead hazard controls on children's blood lead levels and their risk for learning and behavioral problems. Dr. Lanphear has extensive experience conducting community-based trials, including lead poisoning prevention, epidemiology of asthma, prevention of exposureto tobacco smoke and measurement of lead and allergens in housing. Dr. Lanphear, who is a member of the US EPA’s science advisory panel for the national air lead standard, produces videos to show how human health is inextricably linked with the environment and to elevate efforts to prevent disease.

    Michael Lynch, MD

    Medical Director

    Pittsburgh Poison Center

    Kevin F. Maskell, Jr., MD

    Assistant Professor of Military and Emergency Medicine

    Brooke Army Medical Center

    Dr. Maskell is board certified in emergency medicine, medical toxicology, and addiction medicine.  He has an appointment as Assistant Professor of Military and Emergency Medicine at Uniformed Services University of Health Sciences and currently serves as the Medical Director of the Tactical Medicine Readiness Division at the US Army Medical Department Medical Center of Excellence, Ft. Sam Houston, Texas.  He also serves as guest faculty at Brooke Army Medical Center and as a Consulting Toxicologist for the Washington Poison Center.  He graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science, completed his Emergency Medicine residency at Madigan Army Medical Center in Tacoma, Washington, and his Medical Toxicology fellowship at Virginia Commonwealth University in Richmond, Virginia.  

    Dan McCabe, MD

    Associate Professor

    University of Iowa Hospitals & Clinics, Iowa Poison Control Center

    Dr. Dan McCabe is a Clinical Associate Professor of Emergency Medicine and Pharmacy at the University of Iowa, Division Director of Medical Toxicology at the University of Iowa, and Medical Director for Iowa Poison Control Center.

    Lisa Moreno-Walton, MD, MS, MSCR, FAAEM, FIFEM

    Professor of Clinical Emergency Medicine

    Louisiana State University Health Sciences Center

    Nancy Murphy, MD, FACEP, FAAEM, FACMT, FAACT, FASAM

    President

    Canadian Association for Poison Centres and Clinical Toxicology

    Dr. Murphy is the current President of the Canadian Association of Poison Centres and Clinical Toxicology and Medical Director of the Atlantic Canada Poison Centre. She is an Associate Professor at Dalhousie University in the Department of Emergency Medicine. Dr. Murphy completed her medical toxicology fellowship at the University of California, San Francisco and is American Board certified in Medical Toxicology and Addiction Medicine.

    Nicholas E. Nacca, MD, FACMT

    Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Associate Fellowship Director of Medical Toxicology Fellowship Program

    University of Rochester Medical Center

    Nicholas E. Nacca, MD, FACMT is an Assistant Professor of Emergency Medicine, Director of Medical Toxicology, and Associate Fellowship Director of the Medical Toxicology Fellowship Program at the University of Rochester Medical Center (URMC). In addition to his role within the Department of Emergency Medicine, Dr. Nacca holds a secondary appointment in the Department of Environmental Medicine. As Director of Medical Toxicology, Dr. Nacca oversees the educational and clinical operations of the medical toxicology consultation service, where he is actively involved in training medical toxicology fellows, as well as mentoring multidisciplinary teams that include medical residents, pharmacy residents, and medical students. He also staffs and directs a referral-based outpatient Medical Toxicology Clinic, where he provides specialized care to patients requiring toxicological evaluation and treatment. Dr. Nacca’s work bridges clinical practice and education, emphasizing the development of the next generation of toxicology professionals while providing expert consultation in both inpatient and outpatient settings.

    Mykola Prodanchuk, MD, PhD

    Director, LI Medved Research Center of Preventive Toxicology

    Ministry of Health, Ukraine

    Dr. Mykola Prodanchuk is a renowned toxicologist, professor, and doctor currently serving as Director of the L.I. Medved's Research Center of Preventive Toxicology in Kyiv, Ukraine. He has held key roles, including State Sanitary Doctor and Deputy Minister of Health, and is a member of Ukraine's Academy of Medical Science.

    As a consultant to the Ukrainian Parliament and Minister of Health, he has contributed to major health policies and legislation. He has also worked with international bodies like WHO, UNEP, and the World Bank. Mykola is a member of EUROTOX, IUTOX, the Society of Toxicology of the USA, and the American Public Health Association

    Kerollos Shaker, MD, FACEP

    Board Certified Emergency Medicine and Medical Toxicologist

    Houston Methodist The Woodlands

    Dr. Kerollos Shaker is a board certified Emergency Medicine Physician and Medical Toxicologist in Houston, Texas. He graduated from University of Alabama School of Medicine. He completed residency in Emergency Medicine and fellowship in Medical Toxicology. Currently practicing as an ER Doctor and Toxicologist Consultant. He is also a Laboratory Director with experience in high-complexity labs.

    Michael Simpson, MD

    Emergency Medicine Physician

    Beth Israel Deaconess Medical Center

    Dr. Simpson is an emergency physician and medical toxicologist at Beth Israel Deaconess Medical Center. He completed his residency at Vanderbilt University Medical Center and his medical toxicology fellowship at the Harvard Medical Toxicology Fellowship. He is a current T32 fellow with the Center for Resuscitation Science at BIDMC. His research interests include prediction and management of cardiovascular toxicity in acute drug overdose as well as bupropion cardiotoxicity.

    Hannah Spungen, MD, MPH

    Assistant Clinical Professor

    UCLA Health/David Geffen School of Medicine

    Dr. Spungen is a second year Medical Toxicology fellow at Banner—University Medical Center Phoenix. She completed her Emergency Medicine residency at UCLA Ronald Reagan/Olive View. Her research interests include bias and spin in scientific communication, vasopressor dosing in cardiodepressant drug toxicity, and using R to explore large toxicologic data sets. 

    Paul M. Wax, MD, FACMT

    Executive Director

    American College of Medical Toxicology (ACMT)

    Dr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.

    Timothy Wiegand, MD, DFASAM, FACMT, FAACT

    Director of Addiction Medicine and Addiction Medicine Consults

    University of Rochester Medical Center

    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

    Rachel Wightman, MD, FACMT

    Assistant Professor of Emergency Medicine

    The Warren Alpert Medical School of Brown University

    Dr. Wightman is an Assistant Professor of Emergency Medicine at Alpert Medical School of Brown University. She is a triple board-certified practicing physician in medical toxicology, addiction medicine, and emergency medicine. She serves as Director of Toxicology Education for Brown Emergency Medicine and as faculty in the Addiction Medicine Fellowship at Rhode Island Hospital. She completed medical toxicology fellowship and emergency medicine residency at New York University School of Medicine/ Bellevue Hospital Center. 

    Dr. Wightman’s primary clinical expertise is in the evaluation and management of drug toxicity syndromes in complex medical patients and enhancing medication safety for high-risk drugs. Her research is focused on evaluation and tracking of emerging drug trends, cannabis hyperemesis syndrome, and medications for treatment of opioid use disorder.

    Michael Yeh, MD, MS

    Medical Toxicology Physician

    Centers for Disease Control and Prevention (CDC), National Center for Environmental Health (NCEH)

    Michael Yeh is a medical toxicology physician in CDC's National Center for Environmental Health (NCEH) and a Lieutenant Commander in the U.S. Public Health Service Commissioned Corps. Michael graduated with a B.S. in biology from SUNY Stony Brook, an M.S. in journalism from Columbia University, as well as an M.S. in epidemiology and M.D. from the University at Buffalo, SUNY. He completed a combined internal medicine and emergency medicine residency at Allegheny General Hospital in Pittsburgh. Prior to joining CDC, Michael worked as an emergency physician in Patchogue, NY (Long Island) and in Westerly, Rhode Island, before completing the Emory University/CDC medical toxicology fellowship in 2021. Michael's activities at CDC include working with America’s Poison Centers on surveillance of chemical exposures and public health hazards, acute toxicologic outbreak investigations, emergency preparedness for chemical and radiological disasters, and medical toxicology fellow education.

    Shan Yin, MD, FACMT

    EM physician and Medical Toxicologist

    Cincinnati Children’s Hospital

    Dr. Yin currently serves as the medical director of the Cincinnati Poison Drug and Information Center where he has been since 2010. He is an associate professor of pediatrics at the University of Cincinnati School of Medicine and also works clinically as a pediatric emergency medicine attending at Cincinnati Children’s Hospital.

    Dr. Yin is on the editorial board for the American Academy of Pediatrics (AAP) published journal - Pediatrics in Review and a peer reviewer for a number of pediatrics journals. He also administers and is the primary educator for a toxicology rotation for pediatric emergency medicine fellows, child abuse fellows, pediatric residents, med-peds residents, and pharmacy residents.

    Continuing Education

    image

    Continuing Education credit for this activity is available for an additional fee. 

    Accreditation is provided by AKH Inc., Advancing Knowledge in Healthcare, and registrants will be able to claim up 15.50 credits, commensurate with their participation. 

    Available Continuing Educations Credits:

    • Continuing Medical Education (CME)
    • Continuing Pharmacist Education (CPE)
    • Continuing Nursing Education (CNE)


    Purchase/Claim CE

    Travel Info

    ACMT is heading to Vancouver for the 2025 ACMT Annual Scientific Meeting & Symposia! If you are a US Citizen, you will need a valid passport to enter Canada. Citizens of other countries may need additional documentation, like a Visa. Not sure what documents you’ll need? No problem! Click on the button below to find out what sorts of identity documents you will need to successfully enter Canada and attend #ACMT2025.

    Find Out If You Need a Visa to Travel to Canada


    Visa Information

    Obtaining a Visa to enter Canada is the responsibility of the participants. ACMT has registered this conference with the Immigration, Refugees and Citizenship Canada’s (IRCC) Special Events Liaison Unit (SELU) and can assist you by issuing an invitation letter, however, we are not involved in the visa issuing process, this is solely the responsibility of the competent Canadian embassy or consulate.

    You must be registered participant to be considered for an invitation letter. ACMT is not allowed to issue invitation letters to anyone who has not fully paid their conference registration fee. To avoid any delays, we encourage all those who need a visa to enter Canada, to register as early as possible and apply for the visa.

    Request Letter of Invitation


    Hotel – Discounted Group Block

    ACMT has secured a discounted rate for attendees of our 2025 ACMT Annual Scientific Meeting & Symposia. We encourage you to book your stay at the conference hotel for the best selection and price!

    Fairmont Hotel Vancouver
    900 West Georgia St.
    Vancouver, BC VC6 2W6

    Exclusive hotel rate available until March 10, 2025 or when room block is filled, whichever comes first.

    Book Your Stay

    First-Time Attendees will be assigned buddies!

    New to ACMT and/or our conference? If you're a first-time attendee, you'll be automatically assigned a Buddy to enhance your conference experience! Your Buddy/Member will be a friendly, knowledgeable guide to show you around, introduce you to key sessions, and help you network with other attendees. They will be available to answer your questions and provide insights to ensure you feel welcomed and well-prepared. By having a Buddy, you'll gain a head start in making meaningful connections and fully benefiting from all the opportunities our conference has to offer. Don't miss this chance to start your ACMT journey with a supportive community right by your side.


    Invitation to Serve as a Buddy

    Are you a seasoned ACMT member who loves to share your knowledge and enthusiasm? We invite you to become a Buddy for our upcoming conference! As a Buddy, you'll have the opportunity to welcome new members, show them around, and help them navigate the event. It's an easy gig where you'll make yourself available for introductions and Q&A, ensuring that our new attendees feel at home and can make the most of their conference experience. Volunteering as a Buddy is a fantastic way to give back to the ACMT community, build new connections, and reinforce the collaborative spirit that makes our association special. Join us in creating a warm, inclusive environment where everyone can thrive.


    • Register
      • Early bird pricing available!
      • Non-member - Tier I - $950
      • Non-member - Tier II - $650
      • Non-member - Tier III - $550
      • Non-member - Tier IV - $450
      • Member - Tier I - $650
      • Member - Tier II - $450
      • Member - Tier III - $350
      • Member - Tier IV - $250
      • Regular Price after 02/21/2025 11:59 PM
      • Non-member - Tier I - $1,050
      • Non-member - Tier II - $750
      • Non-member - Tier III - $650
      • Non-member - Tier IV - $550
      • Member - Tier I - $750
      • Member - Tier II - $550
      • Member - Tier III - $450
      • Member - Tier IV - $350
    • More Information
  • CE Credit available
    Contains 4 Component(s) Includes a Live In-Person Event on 04/03/2025 at 9:45 AM (PDT)

    April 3, 2025

    2025 ACMT Symposium | Harm Reduction in the Management of SUD

    April 3, 2025
    Fairmont Hotel, Vancouver Canada

    Join the American College of Medical Toxicology (ACMT) on Thursday, April 3, 2025 for the ACMT Symposium: Harm Reduction in the Management of SUD at the Fairmont Hotel in Vancouver, Canada.

    Harm reduction has become a key tool in managing substance use disorders (SUD), yet remains loosely defined. It encompasses various measures, including needle exchanges, naloxone distribution, safe consumption sites, and fentanyl test strips. While needle exchange programs have proven effective in reducing infections from intravenous drug use, the impact of other harm reduction strategies is harder to quantify.

    Support for harm reduction varies among professionals and the recovery community, with its success depending on when and where the tools are used, the methods chosen, and the combination with other treatments. Different settings—emergency departments, ICUs, or outpatient clinics—may require distinct approaches.

    Vancouver’s pioneering leadership in harm reduction makes it an ideal location for this full-day in-person symposium, which will explore harm reduction in detail, presenting the latest evidence and examining its application in special populations, healthcare settings, and recovery stages. Topics include integrating harm reduction with SUD medications and substance use education, inpatient high-dose methadone titration, and a case-based panel discussion on “Lived Experience.” The symposium will appeal to a wide range of professionals in medicine, including those in family medicine, emergency medicine, medical toxicology, addiction medicine, and beyond.


    Learner Objectives

    After attending the event, participants should be able to:

    • Analyze the evidence surrounding various harm reduction strategies in the management of substance use disorders, with a focus on their effectiveness across different settings and populations.
    • Evaluate the role of harm reduction tools at different stages of the recovery process and identify how they can be integrated with other treatment modalities to optimize patient outcomes.
    • Discuss the ethical and practical considerations of harm reduction practices, including the perspectives of healthcare providers, patients, and the broader recovery community.

    Continuing Education

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity. It is expected that learners will receive up to 6.00 credits for learning and change. These credits are available for an additional fee. Click here for more info.


    Questions?

    Please write to ACMT at events@acmt.net

    Preliminary Agenda | April 3, 2025

    All times listed are in local, Pacific Time.


    7:00 - 9:00 AM PT 

    Optional Fieldtrip: Insite, Supervised Injection Site

    Purchase ticket. Cost: $40

    Those who register will be transported by charter bus from the conference hotel to Insite for this unique opportunity to witness harm reduction practices firsthand and explore the impact of North America's first supervised injection site on the local community. This opportunity is limited to #ACMT2025 Harm Reduction Symposium registrants only, and there are only 25 seats available on the bus, so be sure to sign up early!


    9:45 - 10:00 AM PT

    Welcome & Opening Remarks

    10:00 - 11:00 AM PT

    Donovan Lecture | On the Streets with Evolving Polysubstance Use — The Rise of 'Fentanyl-Plus' and Its Impact on Mortality, Morbidity, and Harm Reduction

    Daniel Ciccarone, MD MPH, Justine Miner Professor of Addiction Medicine, Family and Community Medicine, UCSF, San Francisco, CA

    This lectureship is supported by the Medical Toxicology Foundation through the Ward and Ryan Donovan Memorial Fund. For more info, please visit: www.acmt.net/donovan-lectureship.


    11:00 - 12:00 AM PT

    Politics and History of Harm Reduction in Vancouver, Successes & Challenges

    Patricia Daly, MD, Chief Medical Health Officer, Vancouver Coastal Health; Clinical Professor, School of Population and Public Health, Faculty of Medicine at the University of British Columbia, Vancouver, Canada


    12:00 - 1:15 PM PT | Lunch Break (75 min)


    1:15 - 2:00 PM PT

    Lived Experience in Action: Harm Reduction and Recovery in Vancouver's Downtown Eastside

    Guy Felicella, International Public Speaker, Drug Policy Advocate, Vancouver


    2:00 - 2:45 PM PT

    Voices of Experience: A Discussion on Living and Practicing Harm Reduction

    Moderator: Leslie Dye, MD FACMT FASAM, Medical Director, OneFifteen; Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University, Dayton, OH

    Panelists:
    Daniel Ciccarone, MD MPH, Justine Miner Professor of Addiction Medicine, Family and Community Medicine, UCSF, San Francisco, CA
    Patricia Daly, MD, Chief Medical Health Officer, Vancouver Coastal Health; Clinical Professor, School of Population and Public Health, Faculty of Medicine at the University of British Columbia, Vancouver, Canada
    Guy Felicella, International Public Speaker, Drug Policy Advocate, Vancouver


    2:45 - 3:30 PM PT

    Integrating Harm Reduction with Prevention, Treatment, and Personal Accountability: Saving Lives Without Creating Pill Mills 2.0

    Leslie Dye, MD FACMT FASAM, Medical Director, OneFifteen; Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University, Dayton, OH


    3:30 - 4:00 PM PT

    Rapidly Increasing Methadone Doses, Scaring Medical Toxicologists

    Robert Cole Pueringer, MD, Medical Toxicologist and Addiction Medicine Specialist, Essentia Health, Duluth, MN


    4:00 - 4:15 PM PT - Break (15 min)


    4:15 - 5:00 PM PT

    Integrating Harm Reduction Approaches in Hospital Care: Inpatient Substance Use Policies

    Moderator: Anthony Spadaro, MD, Fellow-in-Training, Rutgers New Jersey Medical School, Rutgers, NJ

    Panelists:
    Gillian Beauchamp, MD, FACMT, FASAM, Program Director, Medical Toxicology Fellowship; Associate Professor, Lehigh Valley Health Network; USF Morsani College of Medicine, Allentown, PA
    Evan Schwarz, MD, FACMT, Associate Professor of Emergency Medicine, University of California, Los Angeles, CA


    5:00 - 5:45 PM PT

    Timing is Everything: Harm Reduction for Special Populations — An Interactive Case-Based Discussion of Who, When, and Where

    Moderator: Ashley Haynes, MD FACEP, Medical Toxicologist, Addiction Medicine Specialist, Veterans Health Administration, Andover, KS

    Panelists:
    JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN
    Timothy J. Wiegand, MD FACMT DFASAM, Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY


    5:45 - 6:oo PM PT 

    Closing Remarks


    Daniel Ciccarone, MD, MPH

    Justine Miner Professor of Addiction Medicine

    University of California, San Francisco

    Dr. Daniel Ciccarone is the Justine Miner Professor of Addiction Medicine in the Department of Family & Community Medicine at the University of California, San Francisco. A specialist in Family Medicine and Addiction Medicine, Dr. Ciccarone has served as principal or co-investigator on numerous NIH-funded public health research projects. He currently leads the Heroin in Transition study, a multidisciplinary effort employing ethnographic, economic, and statistical modeling to explore the rise in heroin use, the growing variety of heroin source-forms, and the impact of illicitly manufactured synthetic opioids, such as fentanyls, on opioid-related mortality and morbidity. His research has been widely published in leading journals, including JAMA, NEJM, AJPH, IJDP, and PLoS Medicine. Additionally, Dr. Ciccarone serves as Associate Editor for the International Journal of Drug Policy and recently edited a special issue on the “triple wave crisis” of opioids, heroin, and fentanyl in the U.S.

    Patricia Daly, MD

    Chief Medical Health Officer, Vancouver Coastal Health;

    Clinical Professor, School of Population and Public Health, Faculty of Medicine, University of British Columbia

    Dr. Patricia Daly is the Vice President, Public Health and Chief Medical Health Officer for Vancouver Coastal Health and a Clinical Professor in the School of Population and Public Health at the University of British Columbia. As a public health physician, she focuses on improving population health through prevention, health promotion, communicable disease control, environmental health, and public health surveillance. Dr. Daly earned her medical degree from the University of Toronto in 1985 and worked as a family and emergency physician before completing specialty training at McGill University and the University of Toronto, earning a fellowship in Community Medicine in 1992. After moving to Vancouver in 1993, she served at the BC Centre for Disease Control and later at the Vancouver/Richmond Health Board. Since the formation of Vancouver Coastal Health in 2001, she has continued to lead communicable disease control efforts, assuming her current role in 2007. In addition to her leadership duties, Dr. Daly consults with health professionals, advises the public on key health issues, and teaches medical students and residents at UBC.

    Guy Felicella

    International Public Speaker, Drug Policy Advocate

    BC Center on Substance Use

    Guy Felicella, raised in a middle-class home in British Columbia, fell into addiction at a young age due to trauma, undiagnosed ADHD, and struggles at home and school. He spent 30 years trapped in cycles of gangs, addiction, treatment, and jail, including two decades living homeless in Vancouver's Downtown Eastside, surviving the HIV/AIDS crisis, severe infections, and six overdoses. Now with over a decade of sobriety, Guy lives with his wife and three children and is a passionate advocate for harm reduction, recovery, and ending addiction stigma. A sought-after international speaker, he shares his story at conferences, schools, and TEDx Talks, inspiring hope and educating communities on the importance of comprehensive care.

    Gillian Beauchamp, MD, FACMT, FASAM

    Program Director, Medical Toxicology Fellowship; Associate Professor

    Lehigh Valley Health Network; USF Morsani College of Medicine

    Gillian Beauchamp, MD, is fellowship director for the Lehigh Valley Health Network (LVHN) Medical Toxicology fellowship; core faculty for the LVHN emergency medicine residency; Associate professor, USF Morsani College of Medicine; LVHN Medical director for acute care substance use and prevention; Co-chair, LVHN Opioid Stewardship and Linkage to Treatment Committee; and Vice Chair for Education and Community Engagement in the Lehigh Valley Health Network Department of Emergency and Hospital Medicine. She is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine. She is an Editorial board member for Toxicology Communications and a Reviews Section Editor and Editorial board member for the Journal of Medical Toxicology; She is co-host for the Tox in Ten: ACMT Highlights podcast and oversees the ACMT online toxicology lecture library as a member of the ACMT Education Committee.

    Leslie R. Dye, MD FACMT FASAM

    Medical Director, OneFifteen

    Clinical Professor, Department of Emergency Medicine, Boonshoft School of Medicine, Wright State University

    Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

    Ashley Haynes, MD, FACEP

    Medical Toxicologist, Addiction Medicine Specialist

    Veterans Health Administration

    Dr. Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addition medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, as well as clinic, and performing bedside consults.

    JoAn Laes, MD, DFASAM, FACMT

    Addiction Staff Physician

    Abbott Northwestern Hospital, Allina Health

    JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

    Robert Cole Pueringer, MD

    Medical Toxicologist and Addiction Medicine Specialist

    Essentia Health

    Dr. Robert “Cole” Pueringer is a Medical Toxicologist, Addiction Medicine Specialist, and Hospitalist. He joined Essentia Health in September of 2022. He completed his medical training in the Twin Cities, including Medical School at the University of Minnesota, Internal Medicine Residency and Chief Resident year at Hennepin County Medical Center (HCMC). He received his CTropMed certification for Tropical Medicine & Travelers’ Health at the University of Minnesota. He then completed a Medical Toxicology fellowship at the Health Partners Institute/HCMC in 2021 and an Addiction Medicine fellowship at the University of Minnesota in 2022. His academic interests include medical education, Global Health, and the overlap of Medical Toxicology and Addiction Medicine. He is particularly passionate about substance use disorder - a disease that has affected many aspects of his own life – and hopes to contribute significantly to substance use treatment, education, de-stigmatization, and harm reduction in northern Minnesota.

    Evan Schwarz, MD, FACMT

    Associate Professor of Emergency Medicine

    University of California, Los Angeles

    Dr. Schwarz attended medical school at the University of Texas Medical Branch in Galveston, Texas, before completing a residency in Emergency Medicine at the Washington University School of Medicine in Saint Louis, Missouri.  After residency, he completed a fellowship in Medical Toxicology at the University of Texas Southwestern School of Medicine in Dallas, Texas, before returning to Missouri where he was an Advisory Dean and the Medical Toxicology Division Chief and Fellowship Director at Washington University. In 2023, he took a position in the Department of Emergency Medicine at the University of California Los Angeles. He is also a member of the Board of Directors for ACMT.

    Anthony Spadaro, MD

    Fellow-in-Training

    Rutgers New Jersey Medical School

    Timothy Wiegand, MD, DFASAM, FACMT, FAACT

    Director of Addiction Medicine and Addiction Medicine Consults

    University of Rochester Medical Center

    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

    Registration Rates

    Registration includes:

    • Access to the live in-person event on Thursday, April 3, 2025

    • Access to the on-demand recording for 90 days after the event

    • Access to the speaker slides

    • Continuing Education credits are available for purchase for an additional fee. Click here for more info.

    • Insite Field Trip tickets available as an optional add-on. Click here for more info.


    ACMT Member RatesEarly-Bird

    Expires: Feb 21, 2025

    Regular Rate

    Begins: Feb 22, 2025


         Member Tier I: Full, Affiliate, International, Emeritus

    $250
    $300

         Member Tier II: Fellows

    $200
    $250

         Member Tier III: Residents, International - Developing Country


    $125

    $175

         Member IV: Medical Students


    $100

    $150

    Non-Member RatesEarly-Bird

    Expires: Feb 21, 2025

    Regular Rate

    Begins: Feb 22, 2025


         Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"


    $350

    $400

         Non-member Tier II: Fellows, SPIs, Nurses, etc.


    $250

    $300

         Non-member Tier III: Educators & Emergency Responders


    $175

    $225

         Non-member IV: Residents & Students


    $150

    $200


    Early-Bird Rate

    Early-bird rates expire at midnight on FEBRUARY 21, 2025. Fees increase to the Regular Rate after this date, no exceptions.


    ACMT Membership

    ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Team at membership@acmt.net. Learn more at: www.acmt.net/membership


    Refunds and Cancellations

    Event registration cancellations received on or before February 17, 2025 (2/17/25) will receive a full refund less a 8% processing fee. Cancellations received between February 18, 2025 and March 18, 2025 (2/18/25-3/18/25) will receive a 50% refund. Cancellations made on or after March 19, 2025 (3/19/25) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.

    All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

    Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.


    Questions?

    For any questions, please email us at events@acmt.net.

    Continuing Education

    image

    Continuing Education credit for this activity is available for an additional fee. 

    Accreditation is provided by AKH Inc., Advancing Knowledge in Healthcare, and registrants will be able to claim up 6.0 credits, commensurate with their participation. 

    Available Continuing Educations Credits:

    • Continuing Medical Education (CME)
    • Continuing Pharmacist Education (CPE)
    • Continuing Nursing Education (CNE)


    Purchase/Claim CE

    • Register
      • Early bird pricing available!
      • Non-member - Tier I - $350
      • Non-member - Tier II - $250
      • Non-member - Tier III - $175
      • Non-member - Tier IV - $150
      • Member - Tier I - $300
      • Member - Tier II - $250
      • Member - Tier III - $175
      • Member - Tier IV - $150
      • Regular Price after 02/21/2025 11:59 PM
      • Non-member - Tier I - $400
      • Non-member - Tier II - $300
      • Non-member - Tier III - $225
      • Non-member - Tier IV - $200
      • Member - Tier I - $250
      • Member - Tier II - $200
      • Member - Tier III - $125
      • Member - Tier IV - $75
    • More Information
  • CE Credit available
    Contains 3 Component(s) Includes a Live In-Person Event on 04/03/2025 at 8:00 AM (PDT)

    April 3, 2025

    #ACMT2025 | Occupational & Environmental Tox Boot Camp

    April 3, 2025
    Fairmont Hotel, Vancouver Canada

    Join the American College of Medical Toxicology (ACMT) on Thursday, April 3, 2025 for the Occupational & Environmental Tox Boot Camp at the Fairmont Hotel in Vancouver, Canada. This in-person full-day symposium aims to address a crucial gap in toxicology education by focusing on occupational and environmental toxicology. Led by expert medical toxicologists who are also certified in Occupational and Environmental Medicine (OEM), the boot camp targets practicing toxicologists, recent grads, fellows-in-training, and others interested in occupational and environmental toxicology seeking to enhance their knowledge in this field. Through a comprehensive curriculum, attendees will delve into a variety of topics with emphasis on regulatory toxicology, risk assessment, pulmonary toxicology, and reproductive toxicology. Additional topics will include: irritant gasses, organic pollutants, and heavy metals. All sessions are led by specialists who are dually board-certified in both Medical Toxicology and Occupational Medicine. Continuing Education credits for Physicians, Pharmacists, and Nurses available.


    Learner Objectives

    After attending the event, participants should be able to:

    • Define principles of regulatory toxicology. 
    • Identify and manage occupational and environmental toxic exposures.
    • Develop expertise in workplace safety, environmental health, and regulatory compliance.

    Questions?

    Please write to ACMT at events@acmt.net

    Agenda | April 3, 2025

    All times listed are in local, Pacific Time.


    8:00 - 8:15 AM PT 

    Welcome & Opening Remarks

    8:15 - 8:45 AM PT

    Introduction to Regulatory Toxicology

    Michael Holland, MD, FACMT, FAACT, FEACCT, FACOEM, FACEP, SUNY Upstate Medical University, Syracuse, NY 

    Dr. Holland will examine critical occupational health standards, including ACGIH TLVs, BEIs, NIOSH RELs, IDLH values, and OSHA PELs, focusing on their roles in safeguarding workplace safety. He will also delve into historical events, such as the Hawk’s Nest Tunnel silicosis disaster, that have significantly influenced the development of these standards. The session will conclude with practical insights on how to apply these regulatory guidelines to assess and ensure workplace safety and compliance.


    8:45 - 9:15 AM PT

    Introduction to Environmental Toxicology

    John Downs, MD, MPH, Associate Professor, Division of Clinical Toxicology, Virginia Commonwealth University Health System, Richmond, VA

    Dr. Downs will introduce key concepts in environmental toxicology. He will define and explore the roles of EPA Maximum Contaminant Levels (MCLs), Reference Doses (RfD), Reference Concentrations (RfC), Emergency Chemical Exposure Limits (ECEL), National Chemical Exposure Limits (NCEL), the Toxic Substances Control Act (TSCA), Acute Exposure Guideline Levels (AEGL), and Emergency Response Planning Guidelines (ERPG) in environmental health and safety. The lecture will also cover the impact of the Bhopal disaster on environmental toxicology regulations and analyze a recent environmental health issue in the context of regulatory limits.


    9:15 - 9:45 AM PT

    General Causation, Risk Assessment, and Risk Communication

    David J. Vearrier, MD, MPH, Professor of Emergency Medicine, University of Mississippi Medical Center, Madison, MS

    This session will cover the application of Bradford Hill criteria, dose estimation methods, and exposure limits to evaluate risk scenarios and make informed decisions on actions such as evacuation versus sheltering in place. Additionally, Dr. Vearrier will explore the distinction between carcinogenic (no threshold) and non-carcinogenic (threshold) risks and discuss strategies for effectively communicating these risk assessments to stakeholders to guide decision-making.


    9:45 - 10:15 AM PT

    Occupational Dermatology

    Beth Baker, MD, MPH, FACOEM, FACMT, OEM Academic Director, School of Public Health, University of Minnesota, Minneapolis, MN

    Dr. Baker will differentiate between irritant and allergic contact dermatitis, examining critical occupational and environmental risk factors and preventive measures. The session will also cover the systemic signs of dermal absorption and identify key toxicants responsible for systemic poisonings through skin exposure.


    10:15 - 10:30 AM PT | Break (15 min)


    10:30 - 11:00 AM PT

    Occupational Cancer

    Stephen W. Munday, MD, Occupational Medicine Specialist, Sharp Rees-Stealy Chula Vista, San Diego, CA

    This speaker will address occupational cancer and related toxicological concerns. He will distinguish between water-soluble and insoluble irritant gases, including their signs, symptoms, and diagnostic keys. Additionally, the lecture will outline effective treatment strategies for exposure to these different types of irritant gases, providing a comprehensive overview of both prevention and management approaches.


    11:00 - 11:30 AM PT

    Pulmonary Toxicology

    Michael Holland, MD, FACMT, FAACT, FEACCT, FACOEM, FACEP, SUNY Upstate Medical University, Syracuse, NY

    The session will cover the gross and microscopic anatomy of the lungs and its significance in understanding pulmonary toxicology. Dr. Holland will explain how to interpret pulmonary function test results to distinguish between obstructive and restrictive lung patterns. Additionally, this lecture will focus on recognizing and differentiating interstitial lung diseases, such as COPD, BOF, ILD, asbestosis, and silicosis, and understanding their effects on lung function.


    11:30 - 12:00 PM PT

    Asphyxiant Gases

    John G. Benitez, MD, MPH, Retired Medical Director of Emergency Preparedness and Environmental Epidemiology , TN Dept of Health, Nashville, TN

    The session will cover the differentiation between simple and toxic asphyxiants, highlighting their signs, symptoms, and keys to diagnosis. Dr. Benitez will explain appropriate treatment strategies, including antidote administration, for exposure to asphyxiant gases. Additionally, this lecture will focus on real-world applications and case studies to enhance understanding and preparedness for managing asphyxiant gas exposures.


    12:00 - 1:30 PM PT - Lunch Break (90 min)


    1:30 - 2:00 PM PT

    Irritant Gases

    Stephen W. Munday, MD, Occupational Medicine Specialist, Sharp Rees-Stealy Chula Vista, San Diego, CA

    The session will cover the distinction between water-soluble and insoluble irritant gases, highlighting their signs, symptoms, and keys to diagnosis. The speaker will explain effective treatment strategies for exposure to both types of irritant gases. Additionally, this lecture will focus on real-world applications and case studies to enhance understanding and preparedness for managing exposures to irritant gases.


    2:00 - 2:30 PM PT

    Miscellaneous Chemicals Toxicology

    David J. Vearrier, MD, MPH, Professor of Emergency Medicine, University of Mississippi Medical Center, Jackson, MS

    The session will cover the toxicological properties of acids, alkalis, polymers, and solvents, highlighting their mechanisms of action and associated health effects. Dr. Vearrier will explain how to identify solvents that can induce peripheral neuropathy and understand their specific toxicological effects on the nervous system. Additionally, this lecture will focus on real-world applications and case studies to enhance understanding and preparedness for managing exposures to miscellaneous chemicals.


    2:30 - 3:00 PM PT

    Persistent Organic Pollutants (POPs)

    John Downs, MD, MPH, Associate Professor, Division of Clinical Toxicology, Virginia Commonwealth University Health System, Richmond, VA

    Dr. Downs will explore the sources and environmental persistence of select persistent organic pollutants (POPs). He will explain the health and environmental impacts of exposure to POPs, including polychlorinated biphenyls (PCBs), organochlorine pesticides, polychlorinated dioxins, and per- and polyfluoroalkyl substances (PFAS).


    3:00 - 3:30 PM PT

    Metals Toxicology I: Traditional “Heavy Metals” 

    Michael J. Kosnett, MD, MPH, FACMT, Associate Clinical Professor, Department of Medicine, University of Colorado School of Medicine, Denver, CO 

    Dr. Kosnett will identify the traditional heavy metals of major toxicologic significance, including lead, mercury, cadmium, arsenic, and thallium. He will explain their sources and routes of exposure, providing insights into the health risks associated with these metals.


    3:30 - 3:45 PM PT - Break (15 min)


    3:45 - 4:15 PM PT

    Reproductive Toxicology

    Beth Baker, MD, MPH, FACOEM, FACMT, OEM Academic Director, School of Public Health, University of Minnesota, Minneapolis, MN

    In this session, Dr. Baker will describe key reproductive toxicants, including DES, lead, methyl mercury, ethanol, pesticides, and radiation. She will explain their potential effects on parents and offspring, and provide insights into the stages of fetal development and organogenesis where these toxins are most likely to impact fetal development.


    4:15 - 4:45 PM PT

    Pesticides, Herbicides, and Fumigants

    John G. Benitez, MD, MPH, Retired Medical Director of Emergency Preparedness and Environmental Epidemiology , TN Dept of Health, Nashville, TN

    Dr. Benitez will identify and assess the health risks associated with exposure to various pesticides, herbicides, and fumigants. He will cover substances such as organophosphates (OPs), organochlorines, chlorfenopyr, glyphosate, and methyl bromide, providing insights into their health effects and exposure risks.


    4:45 - 5:15 PM PT

    Metals Toxicology II: Other

    Michael J. Kosnett, MD, MPH, FACMT, Associate Clinical Professor, Department of Medicine, University of Colorado School of Medicine, Denver, CO 

    Dr. Kosnett will recognize and explain the adverse health effects of "other" metals of toxicologic importance found in occupational, environmental, and consumer settings. He will cover metals such as beryllium, chromium, cobalt, manganese, nickel, selenium, and zinc, providing insights into their health risks and exposure routes.

    Beth Baker, MD, MPH, FACOEM, FACMT, OEM

    Academic Director, School of Public Health

    University of Minnesota

    Dr. Beth Baker is the Academic Program Director for Occupational and Environmental Medicine at the Midwest Center for Occupational Health and Safety, University of Minnesota School of Public Health. She previously served as the HealthPartners/ U of MN OEM residency program director and lectured in the U of MN OEM course (PubH 6170) since 2006. She has practiced Occupational and Environmental Medicine in the Twin Cities for over 30 years, and is currently on the board of directors of the American Board of Preventive Medicine, a Past President of the American College of Occupational and Environmental Medicine, and a Past Trustee of the Minnesota Medical Association.

    John G. Benitez, MD, MPH

    Retired Medical Director of Emergency Preparedness and Environmental Epidemiology

    Tennessee State Health Department

    Dr. John G. Benitez completed his Medical Doctorate at Southern Illinois University, Springfield, and a Master of Public Health (MPH) degree at University of Pittsburgh. He completed a surgical residency at Southwestern Michigan Area Health Education Center, a hyperbaric medicine “mini-fellowship” at St. Luke's Hospital in Milwaukee, WI, a medical education fellowship at the University of Texas Southwestern Medical Center in Dallas, and completed a fellowship in clinical toxicology at Vanderbilt University. Dr. Benitez is the retired medical director for the emergency preparedness program at the Tennessee State Health Department. Previously, Dr. Benitez was appointed professor of clinical medicine at Vanderbilt University in Nashville where still holds an appointed as adjunct professor. He was also associate professor of clinical emergency medicine, community and preventive medicine, environmental medicine, and pediatrics at the University of Rochester, New York, where he also worked as the managing director of the RA Lawrence Poison and Drug Information Center. From 2000-2008, he was director for regional emergency preparedness at the University of Rochester Medical Center, medical director of the Pittsburgh Poison Center, and director of the multidisciplinary MPH program at the University of Pittsburgh Graduate School of Public Health. He is a member of the National Academies of Science, Engineering, and Medicine’s Committee on Strengthening the Disaster Resilience of Academic Research Communities. Dr. Benitez is also a member of the U.S. Army Reserves, where he holds the rank of Colonel and serves as a Preventive Medical Officer.

    John Downs, MD, MPH

    Associate Professor and Director, Virginia Poison Center

    Virginia Commonwealth University Health System

    John W. Downs, MD MPH, is a graduate of the Virginia Military Institute and served two years as a US Army infantry officer, prior to attending medical school at the Uniformed Services University of the Health Sciences (USU). Dr. Downs completed residency training in internal medicine at Tripler Army Medical Center, Honolulu, Hawaii, and in occupational & environmental medicine at USU, where he also completed a Master of Public Health degree. Dr. Downs later completed a fellowship in medical toxicology at the Virginia Commonwealth University (VCU) Health System. Prior to his recent arrival as medical toxicology faculty at VCU in summer 2024, Dr. Downs was a US Army officer for more than 20 years. His final active-duty tour was at the Uniformed Services University where he was an Associate Professor and the Associate Program Director for the Occupational and Environmental Medicine residency, and an attending physician at Walter Reed National Military Medical Center. 

    His military medical experience includes multiple tours as senior medical officer to special operations and light infantry units to include deployments to operations in Iraq and Afghanistan. Dr. Downs’s public health experience includes service as Chief of the Department of Preventive Medicine at Fort Campbell, Kentucky, and Chief, Occupational & Environmental Medicine Service, Walter Reed National Military Medical Center during the COVID-19 pandemic. Dr. Downs is board certified as a physician in internal medicine, occupational & environmental medicine, and medical toxicology. Dr. Downs also holds allied health certifications as a certified public health professional (CPH), and Diplomate of the American Board of Toxicology (DABT). Dr. Downs is a recipient of the Army Surgeon General’s 9A Proficiency Designation in occupational and environmental medicine. He has authored more than 25 peer-reviewed publications. He is a Fellow of the American College of Physicians, and the American College of Occupational and Environmental Medicine.

    Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

    Professor of Emergency Medicine

    SUNY Upstate Medical University

    Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

    Michael J. Kosnett, MD, MPH, FACMT

    Associate Clinical Professor, Department of Medicine

    University of Colorado School of Medicine

    Michael J. Kosnett, MD, MPH, FACMT has 34 years of experience as a physician specializing in medical toxicology and occupational and environmental health. He is board certified in internal medicine, medical toxicology, and preventive medicine (occupational medicine). He has served in a leadership and advisory capacity to multiple national and international medical and public health organizations. This includes service as past president of the American College of Medical Toxicology and a member of the Committee on Toxicology of the National Academies of Sciences, Engineering, and Medicine and the Board of Scientific Counselors of the National Institute for Occupational Safety and Health. In addition, Dr. Kosnett has served as a consultant and temporary advisor to the World Health Organization; EPA Science Advisory Board expert panels; and advisory committees of the CDC National Center for Environmental Health and ATSDR. He has also served as a medical toxicology consultant to the US Army Public Health Command, the US Air Force Science Advisory Board, and the US Navy Naval Air Systems Command. In 2016, the American College of Medical Toxicology awarded Dr. Kosnett the Matthew J. Ellenhorn Award, a career achievement award that recognizes “extraordinary contributions to the field of medical toxicology.”

    Stephen W. Munday, MD

    Occupational Medicine Specialist

    Sharp Rees-Stealy Chula Vista

    Dr. Stephen W. Munday is an occupational medicine specialist in San Diego, California and is affiliated with multiple hospitals in the area, including Rady Children's Hospital and Sharp Memorial Hospital. He received his medical degree from University of Florida College of Medicine and has been in practice for more than 20 years.

    David J. Vearrier, MD, MPH

    Professor of Emergency Medicine

    University of Mississippi Medical Center

    Dr. Vearrier is board-certified in occupational medicine, addiction medicine, medical toxicology, and emergency medicine. He obtained his undergraduate degree from University of California Berkeley in 1996 and his Doctor of Medicine degree from University of California San Diego in 2000. He completed his emergency medicine residency at Drexel University College of Medicine in Philadelphia, PA in 2008 and his medical toxicology fellowship at Drexel in 2010. Dr. Vearrier was core faculty for the emergency medicine residency and medical toxicology fellowship at Albert Einstein Healthcare Network from 2010 to 2011 before returning to Drexel University College of Medicine as core faculty for the emergency medicine residency and the medical toxicology fellowship director from 2011 to 2019. He obtained his Master of Public Health degree at Drexel University School of Public Health in 2013. He completed his occupational medicine residency at University of Pennsylvania in Philadelphia, PA in 2015. Dr. Vearrier came to University of Mississippi Medical Center in 2020 where he serves as chief of the division of medical toxicology and service chief for medical toxicology. He is the program director for the medical toxicology fellowship, associate program director for the preventive medicine residency, co-medical director of student and employee health, core faculty for the emergency medicine residency, and the institution’s medical review officer. Dr. Vearrier is very active in academic endeavors having published numerous peer-reviewed publications and book chapters, serving as a peer reviewer for journals in the occupational medicine and medical toxicology fields, and serving as a Chief Editor at Medscape.

    Registration Rates

    Registration includes:

    • Access to the live in-person event on Thursday, April 3, 2025

    • Access to the on-demand recording for 90 days after the event

    • Access to the speaker slides

    • Continuing Education credits are available for purchase for an additional fee. Click here for more info.


    ACMT Member RatesEarly-Bird

    Expires: Feb 21, 2025

    Regular Rate

    Begins: Feb 22, 2025


         Member Tier I: Full, Affiliate, International, Emeritus

    $250
    $300

         Member Tier II: Fellows

    $200
    $250

         Member Tier III: Residents, International - Developing Country


    $125

    $175

         Member IV: Medical Students


    $100

    $150

    Non-Member RatesEarly-Bird

    Expires: Feb 21, 2025

    Regular Rate

    Begins: Feb 22, 2025


         Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"


    $350

    $400

         Non-member Tier II: Fellows, SPIs, Nurses, etc.


    $250

    $300

         Non-member Tier III: Educators & Emergency Responders


    $175

    $225

         Non-member IV: Residents & Students


    $150

    $200


    Early-Bird Rate

    Early-bird rates expire at midnight on FEBRUARY 21, 2025. Fees increase to the Regular Rate after this date, no exceptions.


    ACMT Membership

    ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Team at membership@acmt.net. Learn more at: www.acmt.net/membership


    Refunds and Cancellations

    Event registration cancellations received on or before February 17, 2025 (2/17/25) will receive a full refund less a 8% processing fee. Cancellations received between February 18, 2025 and March 18, 2025 (2/18/25-3/18/25) will receive a 50% refund. Cancellations made on or after March 19, 2025 (3/19/25) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.

    All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

    Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.


    Questions?

    For any questions, please email us at events@acmt.net.

    Continuing Education

    image

    Continuing Education credit for this activity is available for an additional fee. 

    Accreditation is provided by AKH Inc., Advancing Knowledge in Healthcare, and registrants will be able to claim up 7.0 credits, commensurate with their participation. 

    Available Continuing Educations Credits:

    • Continuing Medical Education (CME)
    • Continuing Pharmacist Education (CPE)
    • Continuing Nursing Education (CNE)


    Purchase/Claim CE

    • Register
      • Early bird pricing available!
      • Non-member - Tier I - $350
      • Non-member - Tier II - $250
      • Non-member - Tier III - $175
      • Non-member - Tier IV - $150
      • Member - Tier I - $300
      • Member - Tier II - $250
      • Member - Tier III - $175
      • Member - Tier IV - $150
      • Regular Price after 02/21/2025 11:59 PM
      • Non-member - Tier I - $400
      • Non-member - Tier II - $300
      • Non-member - Tier III - $225
      • Non-member - Tier IV - $200
      • Member - Tier I - $250
      • Member - Tier II - $200
      • Member - Tier III - $125
      • Member - Tier IV - $75
    • More Information
  • CE Credit available
    Contains 3 Component(s) Includes a Live In-Person Event on 04/02/2025 at 11:45 AM (PDT)

    April 2, 2025

    2025 AACT Symposium: Thalli--Ummmm, Was This a Murder?

    11:45-5:30pm PT, Wednesday, April 2, 2025
    Fairmont Hotel, Vancouver Canada

    Join the American Academy of Clinical Toxicology (AACT) on Wednesday, April 2, 2025 for the #ACMT2025 Pre-Symposium: Thalli--Ummmm, Was This a Murder? at the Fairmont Hotel in Vancouver, Canada.

    This comprehensive half-day symposium will focus on the clinical and forensic complexities of thallium poisoning, emphasizing timely access to antidotes and advanced forensic investigation. The program will address themes like pre-hospital management, diagnostic challenges, and the differential diagnosis required in emergency settings. Expert-led sessions will guide attendees through the nuances of patient care, from analytical testing to effective media communication and expert witness testimony.

    This event is designed to enrich the clinical expertise of physicians across multiple specialties, including emergency medicine, toxicology, and forensic medicine, providing the tools needed to optimize patient outcomes in complex poisoning cases.

    AACT Member Discount 

    AACT Members are eligible to receive the same registration rate as ACMT Members for this activity. Just enter the following code at checkout -- a $50 savings! Discount code: AACT2025

    Learning Objectives:

    After attending the event, participants should be able to:

    • Analyze the clinical presentation and diagnostic strategies for thallium poisoning to improve patient assessment and management.

    • Evaluate the effectiveness of various pre-hospital and emergency interventions in cases of suspected thallium toxicity.

    • Asses the role and responsibilities of a medical expert witness, including effective communication strategies for media and courtroom settings.

    Continuing Education

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity. It is expected that learners will receive up to 5.00 credits for learning and change. These credits are available for an additional fee. Click here for more info.


    Questions?

    Please write to ACMT at events@acmt.net

    Registration Rates

    Registration includes:

    • Access to the live in-person event on Wednesday, April 2, 2025

    • Access to the on-demand recording for 90 days after the event

    • Access to the speaker slides

    • Continuing Education credits are available for purchase for an additional fee. Click here for more info.


    ACMT Member RatesEarly-Bird

    Expires: Feb 21, 2025

    Regular Rate

    Begins: Feb 22, 2025


         Member Tier I: Full, Affiliate, International, Emeritus

    $175
    $225

         Member Tier II: Fellows

    $125
    $175

         Member Tier III: Residents, International - Developing Country


    $75

    $125

         Member IV: Medical Students


    $50

    $100

    Non-Member RatesEarly-Bird

    Expires: Feb 21, 2025

    Regular Rate

    Begins: Feb 22, 2025


         Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"


    $225

    $275

         Non-member Tier II: Fellows, SPIs, Nurses, etc.


    $175

    $225

         Non-member Tier III: Educators & Emergency Responders


    $125

    $175

         Non-member IV: Residents & Students


    $100

    $150


    Early-Bird Rate

    Early-bird rates expire at midnight on FEBRUARY 21, 2025. Fees increase to the Regular Rate after this date, no exceptions.


    Membership Discounts

    ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Team at membership@acmt.net. Learn more at: www.acmt.net/membership

    AACT Members are eligible to receive the same registration rate as ACMT Members for this activity. Just enter the following code at checkout -- a $50 savings! Discount code: AACT2025


    Refunds and Cancellations

    Event registration cancellations received on or before February 17, 2025 (2/17/25) will receive a full refund less a 8% processing fee. Cancellations received between February 18, 2025 and March 18, 2025 (2/18/25-3/18/25) will receive a 50% refund. Cancellations made on or after March 19, 2025 (3/19/25) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.

    All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

    Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.


    Questions?

    For any questions, please email us at events@acmt.net.

    Continuing Education

    image

    Continuing Education credit for this activity is available for an additional fee. 

    Accreditation is provided by AKH Inc., Advancing Knowledge in Healthcare, and registrants will be able to claim up 5.0 credits, commensurate with their participation. 

    Available Continuing Educations Credits:

    • Continuing Medical Education (CME)
    • Continuing Pharmacist Education (CPE)
    • Continuing Nursing Education (CNE)


    Purchase/Claim CE

    • Register
      • Early bird pricing available!
      • Non-member - Tier I - $225
      • Non-member - Tier II - $175
      • Non-member - Tier III - $125
      • Non-member - Tier IV - $100
      • Member - Tier I - $175
      • Member - Tier II - $125
      • Member - Tier III - $75
      • Member - Tier IV - $50
      • Regular Price after 02/21/2025 11:59 PM
      • Non-member - Tier I - $275
      • Non-member - Tier II - $225
      • Non-member - Tier III - $175
      • Non-member - Tier IV - $150
      • Member - Tier I - $225
      • Member - Tier II - $175
      • Member - Tier III - $125
      • Member - Tier IV - $100
    • More Information
  • CE Credit available
    Contains 5 Component(s) Includes a Live Web Event on 03/07/2025 at 1:00 PM (EST)

    Acute Toxic Emergencies Related to Cannabis and Marijuana Products

    Acute Toxic Emergencies Related to Cannabis and Marijuana Products

    Cases to be announced soon!


    Learning Objectives

    TBA


    Continuing Education

    1.25 Continuing Education credits for Physicians and Nurses available ($20 certificate fee). Click here for more info.


    About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

    This webinar is free and open to the public.

    Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)

    Director of Addiction Medicine and Addiction Medicine Consults

    University of Rochester Medical Center

    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

    Gloria Baciewicz, MD (Moderator)

    Addiction Psychiatrist

    Strong Recovery

    Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

    Continuing Education
    image

    Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).

    image

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.


    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this live virtual and enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.

    Nurses
    Credit being awarded: 1.25 ANCC contact hours.


    Commercial Support
    There is no commercial support for this activity.


    Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
    Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.

    ACMT Planners and Reviewers: have nothing to disclose.
    AKH Planners and Reviewers: have nothing to disclose.

    None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

    All of the relevant financial relationships listed for these individuals have been mitigated.


    Disclosures

    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

    Disclosure of Unlabeled Use and Investigational Product 

    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer 

    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.

    • Register
      • Non-member - Tier I - Free!
      • Non-member - Tier II - Free!
      • Non-member - Tier III - Free!
      • Non-member - Tier IV - Free!
      • Member - Tier I - Free!
      • Member - Tier II - Free!
      • Member - Tier III - Free!
      • Member - Tier IV - Free!
    • More Information
  • CE Credit available
    Contains 5 Component(s) Includes a Live Web Event on 02/14/2025 at 1:00 PM (EST)

    Driving Impairment and Medical Legal Issues

    Driving Impairment and Medical Legal Issues

    Cases to be announced soon!


    Learning Objectives

    TBA


    Continuing Education

    1.25 Continuing Education credits for Physicians and Nurses available ($20 certificate fee). Click here for more info.


    About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

    This webinar is free and open to the public.

    Jeffrey Brent, MD, PhD, FACMT

    Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care) and Emergency Medicine

    University of Colorado School of Medicine and Public Health

    Jeffrey Brent, MD, PhD, is a Distinguished Clinical Professor of Medicine (Pulmonary and Critical Care Medicine) and Emergency Medicine at the University of Colorado Schools of Medicine and Public Health. He did his fellowship in medical toxicology at the Rocky Mountain Poison and Drug Center, where he has been both medical director and fellowship director. He is a former President of the American Academy of Clinical Toxicology and a former Board member of the American College of Medical Toxicology. Dr. Brent is the senior editor of Critical Care Toxicology: the Diagnosis and Management of the Critically Poisoned Patient, currently in its second edition. Dr. Brent is Co-Principal Investigator of ACMT’s Toxicology Investigators Consortium.

    Barry Logan, PhD, F-ABFT

    Executive Director, Sr. VP & Chief Scientist Forensic Sciences

    Center for Forensic Science Research and Education & NMS Labs

    Dr. Barry Logan is the Senior Vice President of Forensic Sciences and Chief Scientist at NMS Labs, as well as the Executive Director of the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation. A Fellow of the American Board of Forensic Toxicologists (ABFT), Dr. Logan has over 190 publications exploring topics such as the effects of drugs on drivers, drug-related fatalities, and novel psychoactive substances. His current research focuses on new drug surveillance, the polydrug crisis, and the chemistry of emerging substances, leading to the founding of NPSDiscovery.org in 2018. He holds academic appointments at Indiana University, Arcadia University, and Thomas Jefferson University, and serves on the advisory board for NIDA’s National Drug Early Warning System (NDEWS). A past president of the American Academy of Forensic Sciences (AAFS), Dr. Logan was honored with TIAFT’s Alan Curry Award in 2022 for his significant contributions to forensic toxicology.

    Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

    Professor of Emergency Medicine

    SUNY Upstate Medical University

    Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

    Charles McKay, MD, FACMT

    Associate Medical Director

    CT Poison Control Center, University of Connecticut School of Medicine

    Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.

    Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)

    Director of Addiction Medicine and Addiction Medicine Consults

    University of Rochester Medical Center

    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

    Gloria Baciewicz, MD (Moderator)

    Addiction Psychiatrist

    Strong Recovery

    Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

    Continuing Education
    image

    Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).

    image

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.


    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this live virtual and enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.

    Nurses
    Credit being awarded: 1.25 ANCC contact hours.


    Commercial Support
    There is no commercial support for this activity.


    Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
    Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.
    Jeffrey Brent, MD, PhD Faculty: has nothing to disclose
    Barry Logan, PhD, Faculty: has nothing to disclose
    Michael Holland, MD, Faculty: has nothing to disclose
    Charles McKay, MD, Faculty: has nothing to disclose

    ACMT Planners and Reviewers: have nothing to disclose.
    AKH Planners and Reviewers: have nothing to disclose.

    None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

    All of the relevant financial relationships listed for these individuals have been mitigated.


    Disclosures

    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

    Disclosure of Unlabeled Use and Investigational Product 

    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer 

    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.

    • Register
      • Non-member - Tier I - Free!
      • Non-member - Tier II - Free!
      • Non-member - Tier III - Free!
      • Non-member - Tier IV - Free!
      • Member - Tier I - Free!
      • Member - Tier II - Free!
      • Member - Tier III - Free!
      • Member - Tier IV - Free!
    • More Information
  • Contains 4 Component(s) Includes a Live Web Event on 02/11/2025 at 12:00 PM (EST)

    Warfare and Medical Workers: Ukraine War 2022-2023

    Warfare and Medical Workers: A Qualitative Analysis of Female Ukrainian Medical Workers During the Ukraine War 2022-2023

    Presenter: Kristen Kolleda, PhD, MPH, CEM, Director, Emergency Management, University of Kansas Medical Center

    Co-hosted by the American College of Medical Toxicology (ACMT) and the KU Center for Russian, East European, and Eurasian Studies (CREES), this National Grand Rounds will feature a presentation by Dr. Kristen Kolleda on her research study titled "Warfare and Medical Workers: A Qualitative Analysis of Female Ukrainian Medical Workers During the Ukraine War 2022-2023." 

    The ongoing conflict in Ukraine, which began in February 2022, has severely affected civilians and medical infrastructure, with continuous attacks on healthcare facilities impacting access to essential services. Dr. Kolleda’s research examines the experiences of female medical workers in Ukraine, who make up over 83% of the healthcare workforce. Through qualitative, semi-structured interviews, her study explores the health consequences, social impacts, and operational challenges these workers face in a protracted urban conflict. The research categorizes these insights into 50 codes grouped into 10 categories and identifies four overarching themes: health consequences, healthcare operations, social impacts, and survival strategies. The findings also offer recommendations on managing burnout, medical triage in tactical environments, and adapting non-clinical spaces for healthcare operations. Notably, the study addresses the role of animals and pet ownership during traumatic experiences, as well as the importance of continued education for healthcare workers in disaster zones. This webinar will provide valuable insights into the intersection of healthcare, gender studies, and conflict, offering a detailed perspective on the lived experiences of medical professionals during one of the most complex emergencies of recent times.

    Learning Objectives

    • Understand coping strategies employed by female healthcare workers in a time of complex emergency.


    • Recognize types of medical adjustments to operations in times of active conflict. 


    • Reflect on lessons learned and how they might be applicable to disaster preparedness in the United States

    About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.

    Although ACMT National Grand Rounds are usually just for ACMT members, this special session is free and open to the public. Anyone is welcome to join!

    Kristen Kolleda, PhD, MPH, CEM

    Director, Emergency Management

    University of Kansas Medical Center

    Dr. Kristen Kolleda is the Director of Emergency Management for University of Kansas Medical Center.  She also works for Purdue Global as an adjunct professor for their program in emergency management. Kristen has worked in healthcare emergency management for over a decade, with experience in both academic health systems, and pediatric hospitals, working in both urban and rural settings.  She began her role in emergency management after finishing her Master’s in Public Health in Epidemiology with a specialization in Global Emergencies from San Diego State University and completing a fellowship at Children’s Hospital of Philadelphia.  She went on to build emergency management programs at Rideout Health (CA), Prisma Health (SC), and most recently, Children’s Mercy (MO).  She is a Certified Emergency Manager for the International Association of Emergency Managers and currently serves as a Vice Chair for the IAEM Healthcare Caucus. Kristen has received her PhD in Fire and Emergency Management from Oklahoma State University. 

    Nicholas E. Nacca, MD, FACMT (Moderator)

    Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Associate Fellowship Director of Medical Toxicology Fellowship Program

    University of Rochester Medical Center

    Nicholas E. Nacca, MD, FACMT is an Assistant Professor of Emergency Medicine, Director of Medical Toxicology, and Associate Fellowship Director of the Medical Toxicology Fellowship Program at the University of Rochester Medical Center (URMC). In addition to his role within the Department of Emergency Medicine, Dr. Nacca holds a secondary appointment in the Department of Environmental Medicine. As Director of Medical Toxicology, Dr. Nacca oversees the educational and clinical operations of the medical toxicology consultation service, where he is actively involved in training medical toxicology fellows, as well as mentoring multidisciplinary teams that include medical residents, pharmacy residents, and medical students. He also staffs and directs a referral-based outpatient Medical Toxicology Clinic, where he provides specialized care to patients requiring toxicological evaluation and treatment. Dr. Nacca’s work bridges clinical practice and education, emphasizing the development of the next generation of toxicology professionals while providing expert consultation in both inpatient and outpatient settings.

    • Register
      • Non-member - Tier I - Free!
      • Non-member - Tier II - Free!
      • Non-member - Tier III - Free!
      • Non-member - Tier IV - Free!
      • Member - Tier I - Free!
      • Member - Tier II - Free!
      • Member - Tier III - Free!
      • Member - Tier IV - Free!
    • More Information
  • CE Credit available
    Contains 5 Component(s) Includes a Live Web Event on 01/10/2025 at 1:00 PM (EST)

    Benzodiazepine Tapering & Discontinuation Discussion

    Benzodiazepine Tapering & Discontinuation Discussion

    Case 1: Hospital Case

    Case 2: High Risk Patients: Tapering in an Elderly Patient


    Learning Objectives

    1. Demonstrate knowledge of benzodiazepine tapering and discontinuation discussions.

    2. Describe the risks associated with long-term benzodiazepine use.


    Continuing Education

    1.25 Continuing Education credits for Physicians and Nurses available ($20 certificate fee). Click here for more info.


    About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

    This webinar is free and open to the public.

    Maryann Amirshahi, PharmD, MD, MPH, PhD, FACMT

    Emergency Medicine Attending Physician, Professor Of Emergency Medicine, Co-Medical Director

    MedStar Washington Hospital Center, Georgetown University Hospital, National Capital Poison Center

    Dr. Maryann Amirshahi is a Professor of Emergency Medicine at Georgetown University School of Medicine and practices clinically at MedStar Washington Hospital Center, where she specializes in toxicology, addiction care, and emergency medicine. She holds a PharmD and medical degree, alongside an MPH focusing on environmental and occupational health, and a PhD in pharmacology and public health. Dr. Amirshahi is board-certified in emergency medicine, medical toxicology, addiction medicine, and clinical pharmacology, and is a registered pharmacist with over a decade of practice. Nationally recognized, she serves on the Board of Directors for the American College of Medical Toxicology and as co-medical director of the National Capital Poison Center. With nearly 200 peer-reviewed publications, her research spans medication safety, drug shortages, addiction treatment, and prescription drug misuse.

    Emily Brunner, MD, DFASAM

    Physician TTA Consultant

    Hazelden Betty Ford Foundation

    Dr. Emily Brunner is a board-certified family medicine physician and distinguished fellow in addiction medicine, specializing in trauma-informed, compassionate care for substance use disorders. She serves as Medical Director of Gateway Recovery and Recovering Hope and conducts trainings for the Hazelden Betty Ford Foundation. A recognized leader, she has held positions with the Minnesota Society of Addiction Medicine and currently serves on the national board of the American Society of Addiction Medicine. Dr. Brunner is a passionate advocate for expanding access to medications for opioid use disorder and improving care for patients with substance use disorders across the healthcare system. Named a Top Doctor in addiction medicine by Minnesota Magazine in 2020 and 2021, she also has a clinical interest in internet gaming and gambling disorders.

    Richard Scott Dent, MD

    Clinical Senior Instructor

    University of Rochester Medical Center, Rochester, NY

    Dr. Dent began his career teaching elementary and middle school for six years in Texas and California prior returning to school and then obtaining his medical degree from the University of Rochester School of Medicine and Dentistry. He completed his family medicine residency at Lancaster General Hospital in Lancaster, Pennsylvania. Dr. Dent spent his first six years after residency as a primary care physician primarily in urban practices in Rochester.  He has always incorporated addiction medicine in his primary care practice.  In 2018, he transitioned full time into addiction medicine work. From 2019 to 2023, he was the medical director for Chemical Dependency at Rochester Regional Health.  Seeking more clinical and less administrative work, he now works and directs the smaller IMAT Clinic (Individualized Medicine for Addiction Treatment), also through Rochester Regional Health.  He is originally from Rochester, and lives with his wife and 2 boys in Honeoye Falls, NY. 

    Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)

    Director of Addiction Medicine and Addiction Medicine Consults

    University of Rochester Medical Center

    Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center (URMC) in Rochester, New York. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). In 2023, he began a two-year term as Treasurer of ASAM, having previously served as Vice President on the Executive Council. Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.

    Gloria Baciewicz, MD (Moderator)

    Addiction Psychiatrist

    Strong Recovery

    Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.

    Continuing Education
    image

    Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).

    image

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.


    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this live virtual and enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.

    Nurses
    Credit being awarded: 1.25 ANCC contact hours.


    Commercial Support
    There is no commercial support for this activity.


    Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
    Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.

    ACMT Planners and Reviewers: have nothing to disclose.
    AKH Planners and Reviewers: have nothing to disclose.

    None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

    All of the relevant financial relationships listed for these individuals have been mitigated.


    Disclosures

    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

    Disclosure of Unlabeled Use and Investigational Product 

    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer 

    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.

    • Register
      • Non-member - Tier I - Free!
      • Non-member - Tier II - Free!
      • Non-member - Tier III - Free!
      • Non-member - Tier IV - Free!
      • Member - Tier I - Free!
      • Member - Tier II - Free!
      • Member - Tier III - Free!
      • Member - Tier IV - Free!
    • More Information
  • Contains 4 Component(s) Includes a Live Web Event on 12/19/2024 at 1:00 PM (EST)

    Cases to be announced.

    National Case Conference

    Cases to be announced.


    Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

    About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

    Lewis Nelson, MD, MBA, FACMT, FASAM

    Chair of Emergency Medicine

    Rutgers New Jersey Medical School

    Lewis S. Nelson, MD is Professor and Chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, Chief of Service for the Emergency Department at University Hospital of Newark, and Senior Consultant to the New Jersey Poison Information & Education System. Dr. Nelson is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid and other substance use, multimodal pain management strategies, health policy, and medication safety.

    Dr. Nelson has served as President of American College of Medical Toxicology and on the Board of Directors of both the American Board of Emergency Medicine and the Accreditation Council for Continuing Medical Education. He is currently the president of Association of Academic Chairs in Emergency Medicine. He is a long time consultant for several governmental agencies including the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Food and Drug Administration. He is an editor of the textbook “Goldfrank’s Toxicologic Emergencies.

  • Contains 4 Component(s) Includes a Live Web Event on 12/10/2024 at 12:00 PM (EST)

    Camp Lejeune Water Contamination

    Camp Lejeune Water Contamination

    Join ACMT for a National Grand Rounds webinar on Camp Lejeune Water Contamination on Tuesday, December 10, 2024, from 12-1 pm ET, presented by Dr. John Downs, Associate Professor and Director of the Virginia Poison Center. This session will explore the historical and environmental context of water contamination at Camp Lejeune from the 1950s to the 1980s. Attendees will learn about the clinical effects of chronic exposure to hazardous chemicals such as benzene, trichloroethylene (TCE), and perchloroethylene (PCE), and review findings from key epidemiologic studies of affected residents. This grand rounds aims to enhance understanding of the long-term health impacts faced by those exposed.

    Presenter: John Downs, MD MPH, Associate Professor and Director, Virginia Poison Center, Virginia Commonwealth University Health System, Richmond, Virginia

    Target audience: ACMT Members

    Cost: No fee

    Learning Objectives

    • Explain how the Camp Lejeune water supply became contaminated during the 1950s to 1980s.

    • Recall the clinical effects associated with chronic exposure to benzene, trichloroethylene (TCE), and perchloroethylene (PCE).

    • Describe results of epidemiologic studies of Camp Lejeune residents who were exposed to a contaminated water supply.

    About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.

    This webinar is for ACMT members only.

    John Downs, MD, MPH

    Associate Professor and Director, Virginia Poison Center

    Virginia Commonwealth University Health System

    John W. Downs, MD MPH, is a graduate of the Virginia Military Institute and served two years as a US Army infantry officer, prior to attending medical school at the Uniformed Services University of the Health Sciences (USU). Dr. Downs completed residency training in internal medicine at Tripler Army Medical Center, Honolulu, Hawaii, and in occupational & environmental medicine at USU, where he also completed a Master of Public Health degree. Dr. Downs later completed a fellowship in medical toxicology at the Virginia Commonwealth University (VCU) Health System. Prior to his recent arrival as medical toxicology faculty at VCU in summer 2024, Dr. Downs was a US Army officer for more than 20 years. His final active-duty tour was at the Uniformed Services University where he was an Associate Professor and the Associate Program Director for the Occupational and Environmental Medicine residency, and an attending physician at Walter Reed National Military Medical Center. 

    His military medical experience includes multiple tours as senior medical officer to special operations and light infantry units to include deployments to operations in Iraq and Afghanistan. Dr. Downs’s public health experience includes service as Chief of the Department of Preventive Medicine at Fort Campbell, Kentucky, and Chief, Occupational & Environmental Medicine Service, Walter Reed National Military Medical Center during the COVID-19 pandemic. Dr. Downs is board certified as a physician in internal medicine, occupational & environmental medicine, and medical toxicology. Dr. Downs also holds allied health certifications as a certified public health professional (CPH), and Diplomate of the American Board of Toxicology (DABT). Dr. Downs is a recipient of the Army Surgeon General’s 9A Proficiency Designation in occupational and environmental medicine. He has authored more than 25 peer-reviewed publications. He is a Fellow of the American College of Physicians, and the American College of Occupational and Environmental Medicine.

    Nicholas E. Nacca, MD, FACMT (Moderator)

    Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Associate Fellowship Director of Medical Toxicology Fellowship Program

    University of Rochester Medical Center

    Nicholas E. Nacca, MD, FACMT is an Assistant Professor of Emergency Medicine, Director of Medical Toxicology, and Associate Fellowship Director of the Medical Toxicology Fellowship Program at the University of Rochester Medical Center (URMC). In addition to his role within the Department of Emergency Medicine, Dr. Nacca holds a secondary appointment in the Department of Environmental Medicine. As Director of Medical Toxicology, Dr. Nacca oversees the educational and clinical operations of the medical toxicology consultation service, where he is actively involved in training medical toxicology fellows, as well as mentoring multidisciplinary teams that include medical residents, pharmacy residents, and medical students. He also staffs and directs a referral-based outpatient Medical Toxicology Clinic, where he provides specialized care to patients requiring toxicological evaluation and treatment. Dr. Nacca’s work bridges clinical practice and education, emphasizing the development of the next generation of toxicology professionals while providing expert consultation in both inpatient and outpatient settings.